Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$141K Buy
389
+22
+6% +$7.53K 0.01% 86
2026
Q1
$129K Buy
367
+3
+0.8% +$1.07K 0.01% 78
2025
Q4
$119K Buy
364
+2
+0.6% +$634 0.01% 87
2025
Q3
$102K Buy
362
+2
+0.6% +$580 0.01% 85
2025
Q2
$100K Buy
360
+2
+0.6% +$567 0.01% 86
2025
Q1
$111K Buy
358
+3
+0.8% +$886 0.02% 77
2024
Q4
$92.6K Buy
355
+3
+0.9% +$890 0.02% 88
2024
Q3
$113K Buy
352
+2
+0.6% +$654 0.02% 79
2024
Q2
$109K Buy
350
+3
+0.9% +$881 0.02% 83
2024
Q1
$98.7K Buy
347
+3
+0.9% +$878 0.02% 87
2023
Q4
$99.2K Buy
344
+2
+0.6% +$545 0.02% 87
2023
Q3
$91.9K Buy
342
+3
+0.9% +$749 0.02% 92
2023
Q2
$75.3K Buy
339
+3
+0.9% +$696 0.02% 97
2023
Q1
$81.2K Buy
336
+2
+0.6% +$491 0.02% 94
2022
Q4
$87.6K Buy
334
+3
+0.9% +$804 0.03% 91
2022
Q3
$75K Buy
331
+3
+0.9% +$727 0.03% 93
2022
Q2
$80K Buy
328
+2
+0.6% +$490 0.03% 90
2022
Q1
$79K Buy
326
+3
+0.9% +$689 0.02% 96
2021
Q4
$73K Buy
323
+2
+0.6% +$422 0.02% 95
2021
Q3
$68K Buy
321
+2
+0.6% +$460 0.02% 98
2021
Q2
$78K Buy
319
+123
+63% +$30.3K 0.03% 91
2021
Q1
$49K Buy
196
+1
+0.5% +$239 0.02% 101
2020
Q4
$45K Hold
195
0.02% 99
2020
Q3
$50K Hold
195
0.03% 92
2020
Q2
$46K Hold
195
0.03% 92
2020
Q1
$40K Sell
195
-45
-19% -$9.83K 0.03% 88
2019
Q4
$58K Buy
+240
New +$52.9K 0.03% 93

Other funds holding AMGN

Gleason Group's AMGN Position: Q2 2026 in Review

Gleason Group increased its Amgen (AMGN) stake by 6% in Q2 2026, buying an estimated $7.53K and bringing the position to 389 shares worth $141K. The position accounts for 0.01% of the portfolio, ranked #86.

Gleason Group first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gleason Group held 389 shares of Amgen worth $141K as of Q2 2026.
  • Gleason Group bought 22 Amgen shares in Q2 2026, an estimated $7.53K.
  • Amgen made up 0.01% of Gleason Group's portfolio in Q2 2026, its #86 holding.
  • Gleason Group first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.